The Shiga toxin B-subunit targets antigen in vivo to dendritic cells and elicits anti-tumor immunity. (Q40299099)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568496%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

The Shiga toxin B-subunit targets antigen in vivo to dendritic cells and elicits anti-tumor immunity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568496%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568496%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Benoît Vingert

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568496%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Wolf Hervé Fridman

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568496%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Ludger Johannes

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568496%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Eric Tartour

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568496%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Olivier Adotevi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568496%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Delphine Patin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568496%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Protul Shrikant

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568496%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Ludovic Freyburger

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568496%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Cheryl Eppolito

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568496%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Anita Sapoznikov

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568496%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Mohamed Amessou

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568496%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Françoise Quintin-Colonna

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568496%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

English

0 references

publication date

1 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568496%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568496%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568496%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568496%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

1124-1135

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568496%20AND%20SRC:MED&resulttype=core&format=json

Cancer vaccine design: a novel bacterial adjuvant for peptide-specific CTL induction

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

Diphtheria toxin and related proteins: effect of route of injection on toxicity and the determination of cytotoxicity for various cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

The B Subunit of Shiga Toxin Fused to a Tumor Antigen Elicits CTL and Targets Dendritic Cells to Allow MHC Class I-Restricted Presentation of Peptides Derived from Exogenous Antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

Cutting Edge: Intravenous Soluble Antigen Is Presented to CD4 T Cells by CD8- Dendritic Cells, but Cross-Presented to CD8 T Cells by CD8+ Dendritic Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

Mouse and human dendritic cell subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Dendritic cells: immunobiology and cancer immunotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Dendritic cells as vectors for therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Active immunization against cancer with dendritic cells: the near future

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Dendritic cell immunotherapy: mapping the way.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Dendritic cells injected via different routes induce immunity in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

T cell activity after dendritic cell vaccination is dependent on both the type of antigen and the mode of delivery

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

The use of dendritic cells in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Cancer immunotherapy: moving beyond current vaccines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

In vivo manipulation of dendritic cells to induce therapeutic immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

DNA vaccines encoding human immunodeficiency virus-1 glycoprotein 120 fusions with proinflammatory chemoattractants induce systemic and mucosal immune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Glycosphingolipids as toxin receptors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Oral immunization with a shiga toxin B subunit: rotavirus NSP4(90) fusion protein protects mice against gastroenteritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

The B subunit of Shiga toxin coupled to full-size antigenic protein elicits humoral and cell-mediated immune responses associated with a Th1-dominant polarization

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Naive and memory B cells respond differentially to T-dependent signaling but display an equal potential for differentiation toward the centroblast-restricted CD77/globotriaosylceramide phenotype

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

CD77-dependent retrograde transport of CD19 to the nuclear membrane: functional relationship between CD77 and CD19 during germinal center B-cell apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Origin, precursors and differentiation of mouse dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Natural killer dendritic cells have both antigen presenting and lytic function and in response to CpG produce IFN-gamma via autocrine IL-12

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

The role of programming in memory T-cell development

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Dendritic cells in immunity and tolerance-do they display opposite functions?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Cross-priming versus cross-tolerance: are two signals enough?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

The immunologist's grail: vaccines that generate cellular immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Coupling of antigen to cholera toxin for dendritic cell vaccination promotes the induction of MHC class I-restricted cytotoxic T cells and the rejection of a cognate antigen-expressing model tumor.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

In vivo receptor-mediated delivery of a recombinant invasive bacterial toxoid to CD11c + CD8 alpha -CD11bhigh dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Regulated expression of the Shiga toxin B gene induces apoptosis in mammalian fibroblastic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Non-toxic Stx derivatives from Escherichia coli possess adjuvant activity for mucosal immunity.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Nontoxic Shiga toxin derivatives from Escherichia coli possess adjuvant activity for the augmentation of antigen-specific immune responses via dendritic cell activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Prolonged maturation and enhanced transduction of dendritic cells migrated from human skin explants after in situ delivery of CD40-targeted adenoviral vectors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

An adenoviral vector cancer vaccine that delivers a tumor-associated antigen/CD40-ligand fusion protein to dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

New tools for antigen delivery to the MHC class I pathway

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Constitutive versus activation-dependent cross-presentation of immune complexes by CD8(+) and CD8(-) dendritic cells in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

CD8alpha- CD11b+ dendritic cells present exogenous virus-like particles to CD8+ T cells and subsequently express CD8alpha and CD205 molecules.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Robust recall and long-term memory T-cell responses induced by prime-boost regimens with heterologous live viral vectors expressing human immunodeficiency virus type 1 Gag and Env proteins

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8(+) T cell responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Recombinant adenylate cyclase toxin of Bordetella pertussis induces cytotoxic T lymphocyte responses against HLA*0201-restricted melanoma epitopes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Delivery of multiple epitopes by recombinant detoxified adenylate cyclase of Bordetella pertussis induces protective antiviral immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Synthetic and natural non-live vectors: rationale for their clinical development in cancer vaccine protocols

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Rapid antibody responses by low-dose, single-step, dendritic cell-targeted immunization

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Mechanisms and functional significance of tumour-induced dendritic-cell defects

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021

Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535443

7 January 2021